How should a nonfunctioning pituitary macroadenoma be monitored after debulking surgery?
Transsphenoidal surgery is the treatment of choice for nonfunctioning pituitary macroadenomas but is seldom curative. Tumour progression rates are high in patients with postoperative remnants. Therefore, long-term monitoring is necessary to detect tumour growth, which may be asymptomatic or manifest with visual field defects and/or pituitary dysfunction. In view of the generally slow-growing nature of these tumours, yearly magnetic resonance imaging, neuro-ophthalmologic and pituitary function evaluation are appropriate during the first 3-5 years after surgery. If there is no evidence for tumour progression during this period, testing intervals may be extended thereafter.
Greenman
Yona
Y
Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv-Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. greenman@tasmc.heatlh.gov.il
Stern
Naftali
N
D000236:Adenoma / Q000473:pathology / Q000601:surgery*; D003266:Continuity of Patient Care; D006801:Humans; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D010911:Pituitary Neoplasms / Q000473:pathology / Q000601:surgery*; D011182:Postoperative Care; D016896:Treatment Outcome